Samsung Biologics To Produce COVID-19 Treatment
Samsung Biologics will produce COVID-19 treatment once the US firm completed the development of the medicines. Samsung Biologics will produce a treatment that can cure COVID-19 or coronavirus disease once the US firm completed the development of the medicines. This, after Samsung Biologics won a USD 360-million contract to produce biopharmaceutical products from Nasdaq-listed Vir … Read more